Arcus Biosciences Inc
NYSE:RCUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arcus Biosciences Inc
NYSE:RCUS
|
US |
|
G
|
Gesher Acquisition II Corp
NASDAQ:GSHR
|
IL |
|
Lynas Rare Earths Ltd
OTC:LYSCF
|
MY |
|
PhosAgro PAO
LSE:PHOR
|
RU |
|
C
|
Chevron Corp
SWB:CHV
|
US |
|
C
|
CBRE Group Inc
DUS:RF6
|
US |
|
G
|
Givaudan SA
XBER:GIN
|
CH |
|
S
|
Snam SpA
DUS:SNM
|
IT |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
US |
|
L
|
Lam Research Corp
F:LAR
|
US |
|
Cooper Energy Ltd
ASX:COE
|
AU |
|
United Rentals Inc
NYSE:URI
|
US |
|
Aviva PLC
F:GU80
|
UK |
|
A
|
Acrow Formwork and Construction Services Ltd
F:59Y
|
AU |
|
A
|
Autozone Inc
XMUN:AZ5
|
US |
Shareholder Yield
Current shareholder yield for RCUS is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
RCUS Price
Arcus Biosciences Inc
| Average Annual Return | 1.62% |
| Standard Deviation of Annual Returns | 58.42% |
| Max Drawdown | -86% |
| Market Capitalization | 3B USD |
| Shares Outstanding | 125 770 000 |
| Percentage of Shares Shorted | 15.32% |
